INOVIO PHARMACEUTICALS INCINOVIO PHARMACEUTICALS INCINOVIO PHARMACEUTICALS INC

INOVIO PHARMACEUTICALS INC

No trades
See on Supercharts
Market capitalization
‪250.99 M‬EUR
−5.54EUR
‪−122.42 M‬EUR
‪753.81 K‬EUR
‪25.49 M‬
Beta (1Y)
1.52

About INOVIO PHARMACEUTICALS INC

CEO
Jacqueline E. Shea
Headquarters
Plymouth Meeting
Website
Employees (FY)
122
Founded
1983
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GBM is 9.47 EUR — it has decreased by 1.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange INOVIO PHARMACEUTICALS INC stocks are traded under the ticker GBM.
INOVIO PHARMACEUTICALS INC is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
GBM stock is 5.07% volatile and has beta coefficient of 1.52. Check out the list of the most volatile stocks — is INOVIO PHARMACEUTICALS INC there?
GBM earnings for the last quarter are −1.48 EUR per share, whereas the estimation was −1.44 EUR resulting in a −2.63% surprise. The estimated earnings for the next quarter are −1.07 EUR per share. See more details about INOVIO PHARMACEUTICALS INC earnings.
INOVIO PHARMACEUTICALS INC revenue for the last quarter amounts to ‪367.47 K‬ EUR despite the estimated figure of ‪110.37 K‬ EUR. In the next quarter revenue is expected to reach ‪326.16 K‬ EUR.
Yes, you can track INOVIO PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
GBM stock has risen by 3.16% compared to the previous week, the month change is a 11.16% fall, over the last year INOVIO PHARMACEUTICALS INC has showed a 111.86% increase.
GBM net income for the last quarter is ‪−22.65 M‬ EUR, while the quarter before that showed ‪−32.10 M‬ EUR of net income which accounts for 29.42% change. Track more INOVIO PHARMACEUTICALS INC financial stats to get the full picture.
Today INOVIO PHARMACEUTICALS INC has the market capitalization of ‪250.99 M‬, it has increased by 14.92% over the last week.
No, GBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INOVIO PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
GBM reached its all-time high on Mar 28, 2024 with the price of 13.48 EUR, and its all-time low was 4.47 EUR and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 122.00 employees. See our rating of the largest employees — is INOVIO PHARMACEUTICALS INC on this list?
We've gathered analysts' opinions on INOVIO PHARMACEUTICALS INC future price: according to them, GBM price has a max estimate of 36.54 EUR and a min estimate of 7.31 EUR. Read a more detailed INOVIO PHARMACEUTICALS INC forecast: see what analysts think of INOVIO PHARMACEUTICALS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INOVIO PHARMACEUTICALS INC EBITDA is ‪−117.71 M‬ EUR, and current EBITDA margin is ‪−15.83 K‬%. See more stats in INOVIO PHARMACEUTICALS INC financial statements.